SCHEDULE: Thornton Boosts Stake in Regional Health Properties

Robert M. Thornton, Jr. reports a 6.94% beneficial ownership in Regional Health Properties, Inc. following the merger with SunLink Health Systems, Inc. and his new executive role.

Summary

• Robert M. Thornton, Jr. beneficially owns 269,060 shares of Regional Health Properties, Inc. common stock, representing 6.94% of the class, based on 3,834,846 shares outstanding as of August 19, 2025.
• His ownership includes 100,000 shares held directly, 125,663 shares held by CareVest Capital, LLC (which Mr. Thornton solely owns), 1,133 shares held through an IRA, and shares underlying Series D Preferred Stock (41,887 via CareVest and 377 via IRA).
• The shares were acquired as merger consideration from the conversion of 559,562 shares of SunLink Health Systems, Inc. common stock, following the merger of SunLink into Regional Health Properties, Inc. effective August 14, 2025.
• In connection with the merger, Regional Health Properties, Inc. established Series D 8% Cumulative Redeemable Participating Preferred Shares with a $12.50 per share liquidation preference and an 8% annual dividend.
• The Series D Preferred Stock is convertible into common stock at an initial ratio of 1.1330 common shares for every three Series D shares, subject to adjustment, and can be mandatorily converted under specific conditions.
• Mr. Thornton was appointed EVP Corporate Strategy of the Issuer effective August 14, 2025, and received a restricted stock award of 100,000 common shares vesting in equal installments on August 14, 2025, 2026, and 2027.

Sentiment

Score: 7

Explanation: The filing indicates a significant insider stake and commitment through an executive role and restricted stock award following a merger, suggesting positive alignment of interests. No negative disclosures were made.

Positives

• Robert M. Thornton, Jr.'s significant beneficial ownership of 6.94% aligns his interests directly with those of other shareholders.
• His appointment as EVP Corporate Strategy indicates a strong commitment to the Issuer's future direction and integration post-merger.
• The restricted stock award with a multi-year vesting schedule further incentivizes Mr. Thornton's long-term performance and strategic contributions.

Risks

• The Series D Preferred Stock ranks junior to the Issuer's Series B Preferred Stock and all existing and future indebtedness, which could impact recovery in a liquidation event.
• Mandatory conversion of Series D Preferred Stock is contingent on specific conditions (Series B Preferred Stock outstanding below 200,000 shares and common stock average closing price at least $20.00 over 30 trading days), introducing uncertainty regarding future common stock dilution.

Future Outlook

Mr. Thornton intends to remain active in the Issuer's management and strategic direction. He may adjust his holdings based on market conditions and the Issuer's prospects but has no present plans for extraordinary corporate transactions or significant changes to the Issuer's structure, capitalization, or governance, beyond his current role.

Management Comments

• Mr. Thornton takes, and will continue to take, an active role in the Issuer's management and strategic direction.

Industry Context

This filing reflects a post-merger integration phase for Regional Health Properties, Inc., indicating a strategic consolidation within the healthcare real estate or services sector. The appointment of a key executive from the acquired entity (SunLink) to a strategic role in the combined company suggests an emphasis on leveraging prior expertise and ensuring continuity or new strategic direction post-acquisition.

Management Changes

Corporate Governance

Related Party Transactions

• The filing details Robert M. Thornton, Jr.'s beneficial ownership through CareVest Capital, LLC, which he solely owns.
• Mr. Thornton's employment agreement as EVP Corporate Strategy and the associated restricted stock award are related party transactions due to his executive position.

Stakeholder Impact

• Shareholders: The merger and the issuance of Series D Preferred Stock (which ranks senior to common stock for dividends and liquidation) could impact common shareholders. Mr. Thornton's significant beneficial ownership and executive role align his interests with shareholders.
• Employees: Mr. Thornton's appointment as EVP Corporate Strategy indicates a key role in the post-merger organizational structure.

Next Steps

• Mr. Thornton's restricted stock award will vest in substantially equal installments on August 14, 2026, and August 14, 2027.
• The Series D Preferred Stock may mandatorily convert into common stock upon specific conditions related to Series B Preferred Stock outstanding and the common stock price.
• Mr. Thornton may from time to time purchase additional securities or dispose of holdings based on market conditions and other factors.

Key Dates

Recommendation

This Schedule 13D filing primarily reports a significant beneficial ownership stake by a key executive following a merger and the terms of his employment. While the executive's substantial holdings and new strategic role suggest alignment of interests and potential for future growth, the filing itself does not provide new financial performance data or strategic initiatives beyond the merger details. The Series D Preferred Stock terms introduce complexity to the capital structure. Without further operational or financial updates, a "hold" recommendation is prudent, awaiting more comprehensive insights into the combined entity's performance and strategic execution.

Keywords

Regional Health Properties, RHE, SunLink Health Systems, SNLK, SEC filing, Schedule 13D, beneficial ownership, merger, preferred stock, corporate strategy, executive compensation, restricted stock